Cellectar Biosciences, Inc. (CLRB)
NASDAQ·Healthcare·Biotechnology
$2.25
-0.22%
Mkt Cap $8.78M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+434.5%
Consensus $12.00 vs current $2.25
NASDAQ·Healthcare·Biotechnology
$2.25
-0.22%
Mkt Cap $8.78M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+434.5%
Consensus $12.00 vs current $2.25